Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves

Veterinary Parasitology

Volumn 160, Issue 1-2, 2009, Pages 149-154

  Schnyder, M ^a   Kohler, L ^a   Hemphill, A ^b   Deplazes, P ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Calves; Cryptosporidium parvum; Nitazoxanide; Prophylaxis; Treatment

Indexed keywords

NITAZOXANIDE; TIZOXANIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CALF (BOVINE); CONTROL GROUP; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FECES ANALYSIS; GENOTYPE; MAXIMUM PLASMA CONCENTRATION; NEWBORN; NONHUMAN; OOCYST; PROPHYLAXIS;

ANIMALS; ANIMALS, NEWBORN; ANTIPARASITIC AGENTS; CATTLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; THIAZOLES;

BOS; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM;

EID: 59649118022     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.10.094     Document Type: Article

References (33)

1. Appelbee A.J., Thompson R.C.A., and Olson M.E. Giardia and Cryptosporidium in mammalian wildlife-current status and future needs. Trends Parasitol. 21 8 (2005) 370-376
2. Blagburn B.L., Drain K.L., Land T.M., Kinard R.G., Moore P.H., Lindsay D.S., Patrick D.A., Boykin D.W., and Tidwell R.R. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model. Antimicrob. Agents Chemother. 42 (1998) 2877-2882
3. Broekhuysen J., Stockis A., Lins R.L., De Graeve J., and Rossignol J.F. Nitazoxanide: pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38 8 (2000) 387-394
4. Eckert J., Friedhoff K.T., Zahner H., and Deplazes P. Ordnung cryptosporiida. Lehrbuch der Parasitologie für Tiermedizin (2005), Enke Verlag, Stuttgart pp. 91-95
5. Euzeby J., Prom Tep S., and Rossignol J.F. Expérimentation des propriétés anthelminthiques de la nitazoxanide chez le chien, le chat et les ovins. Rev. Méd. Vet. 131 (1980) 687-696
6. Fayer R., and Ellis W. Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves. J. Parasitol. 79 (1993) 771-774
7. Fayer R., Santin M., Trout J.M., Fayer R., Santin M., and Trout J.M. Prevalence of Cryptosporidium species and genotypes in mature dairy cattle on farms in eastern United States compared with younger cattle from the same locations. Vet. Parasitol. 145 (2007) 260-266
8. Fox L.M., and Saravolatz L.D. Nitazoxanide: a new thiazolide antiparasitic agent. Rev. Anti Infect. Agents 40 (2005) 1173-1180
9. Gookin J.L., Levy M.G., Law J.M., Papich M.G., Poore M.F., and Breitschwerdt E.B. Experimental infection of cats with Tritrichomonas foetus. Am. J. Vet. Res. 62 (2001) 1690-1697
10. Grinberg A., Markovics A., Galindez J., Lopez-Villalobos N., Kosak A., and Tranquillo V.M. Controlling the onset of natural cryptosporidiosis in calves with paromomycin sulphate. Vet. Rec. 151 (2002) 606-608
11. Hemphill A., Mueller J., and Esposito M. Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections. Expert Opin. Pharmacother. 7 7 (2006) 953-964
12. Hilbe M., Arquint A., Schaller P., Zlinsky K., Braun U., Peterhans E., and Ehrensperger F. Immunohistochemical diagnosis of persistent infection with Bovine Viral Diarrhoea Virus (BVDV) on skin biopsies. Schweiz. Arch. Tierheilk. 149 (2007) 337-344
13. Hoffman P.S., Sisson G., Croxen M.A., Welch K., Harman W.D., Cremades N., and Morash M.G. Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni. Antimicrob. Agents Chemother. 51 30 (2007) 868-876
14. Jarvie B.D., Trotz-Williams L.A., McKnight D.R., Leslie K.E., Wallace M.M., Todd C.G., Sharpe P.H., Peregrine A.S., Jarvie B.D., Trotz-Williams L.A., McKnight D.R., Leslie K.E., Wallace M.M., Todd C.G., Sharpe P.H., and Peregrine A.S. Effect of halofuginone lactate on the occurrence of Cryptosporidium parvum and growth of neonatal dairy calves. J. Dairy Sci. 88 (2005) 1801-1806
15. Joachim A., Krull T., Schwarzkopf J., and Daugschies A. Prevalence and control of bovine cryptosporidiosis in German dairy herds. Vet. Parasitol. 112 (2003) 277-288
16. Lallemand M., Villeneuve A., Belda J., and Dubreuil P. Field study of the efficacy of halofuginone and decoquinate in the treatment of cryptosporidiosis in veal calves. Vet. Rec. 159 (2006) 672-676
17. Lefay D., Naciri M., Poirier P., and Chermette R. Efficacy of halofuginone lactate in the prevention of cryptosporidiosis in suckling calves. Vet. Rec. 148 (2001) 108-112
18. Li X., Brasseur P., Agnamey P., Lemeteil D., Favennec L., Ballet J.J., and Rossignol J.F. Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol. 50 (2003) 19-22
19. Naciri M., Lefay M.P., Mancassola R., Poirier P., and Chermette R. Role of Cryptosporidium parvum as a pathogen in neonatal diarrhoea complex in suckling and dairy calves in France. Vet. Parasitol. 85 (1999) 245-257
20. Naciri M., Mancassola R., Yvore P., and Peeters J.E. The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves. Vet. Parasitol. 45 (1993) 199-207
21. O'Donoghue P.J. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25 (1995) 139-195
22. Olson M.E., O'Handley R.M., Ralston B.J., McAllister T.A., and Thompson R.C. Update on Cryptosporidium and Giardia infections in cattle. Trends Parasitol. 20 (2004) 185-191
23. Potgieter L.N. Immunology of bovine viral diarrhoea virus. Vet. Clin. North Am. Food Anim. Pract. 11 (1995) 501-520
24. Romero Cabello R., Guerrero L.R., Munoz Garcia M.R., and Geyne Cruz A. Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 701-703
25. Santin M., Trout J.M., Fayer R., Santin M., Trout J.M., and Fayer R. A longitudinal study of cryptosporidiosis in dairy cattle from birth to 2 years of age. Vet. Parasitol. 155 (2008) 15-23
26. Sisson G., Goodwin A., Raudonikiene A., Hughes N.J., Mukhopadhyay A.K., Berg D.A., and Hoffmann P.S. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans and metronidazole in Helicobacter pylori. Antimicrob. Agents Chemother. 46 (2002) 2116-2323
27. Stettler M., Rossignol J.F., Fink R., Walker M., Gottstein B., Merli M., Theurillat R., Thormann W., Dricot E., Segers R., and Hemphill A. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity. Int. J. Parasitol. 34 (2004) 615-624
28. Stockdale H.D., Spencer J.A., and Blagburn B.L. Prophylaxis and chemotherapy. In: Fayer R., and Xiao L. (Eds). Cryptosporidium and Cryptosporidiosis (2008), CRC Press Inc, Boca Raton, FL 255-288
29. Theodos C.M., Griffiths J.K., D'Onfro J., Fairfield A., and Tzipori S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 42 (1998) 1959-1965
30. Torgerson P.R., Shaikenov B.S., Rysmukhambetova A.T., Abdybekova A.M., Usenbayev A.E., and Baitursinov K.K. Modelling the transmission dynamics of Echinococcus granulosus in cattle and sheep in Kazakhstan. Vet. Parasitol. 114 (2003) 143-153
31. Tzipori S., Smith M., Halpin C., Angus K.W., Sherwood D., and Campbell I. Experimental cryptosporidiosis in calves: clinical manifestations and pathological findings. Vet. Rec. 112 (1983) 116-120
32. Viel H., Rocques H., Martin J., and Chartier C. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates. Proceedings of the 21st International Conference of the W.A.A.V.P. Gent, Belgium (2007) 490
33. Ward P.I., Deplazes P., Regli W., Rinder H., and Mathis A. Detection of eight Cryptosporidium genotypes in surface and waste waters in Europe. Parasitology 124 (2002) 359-368